{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:54:30Z","timestamp":1794300870858,"version":"4.9.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We evaluated restenosis rates at the cephalic arch after percutaneous angioplasty and stenting procedures in patients with brachial artery to cephalic vein arteriovenous fistula (BCAVF) hemodialysis access.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used data from adult hemodialysis patients treated at a national network of 44 outpatient interventional facilities during Oct 2011\u20132015. We included data from patients with BCAVF who received an exclusive angioplasty, or stent with angioplasty, for treatment of cephalic arch stenosis and had \u22651 subsequent evaluation of the cephalic arch. Median percent restenosis per month at cephalic arch and days between encounters was calculated from the 1st index to 2nd procedure, and for up to 4 subsequent encounters. Analyses were stratified by intervention and device types.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified a cohort of 3301 patients (mean age 62.2\u2009\u00b1\u200913.9\u2009years, 58.5% male, 33.2% white race) with a BCAVF who had an angioplasty, or stent, at the cephalic arch for an index and\u2009\u2265\u20091 follow-up procedure. Between the 1st index to 2nd procedure, patients who received an angioplasty (<jats:italic>n<\/jats:italic>\u00a0=\u20092663) or stent (<jats:italic>n<\/jats:italic>\u00a0=\u2009933) showed a median decrease of 18.9 and 16.5% in luminal diameter per month and a median time of 93 and 91\u2009days between encounters, respectively. Restenosis and day rates were similar for standard versus high-pressure angioplasties. Bare metal stents showed 10.1 percentage point higher restenosis rate compared to stent grafts. Restenosis rates and time to restenosis were relatively consistent across subsequent encounters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings suggest hemodialysis patients with a BCAVF who require an angioplasty or stent to treat a stenosis at the cephalic arch will have stenosis reformed at a rate of 18.9 and 16.5% per month after the first intervention, respectively. Findings suggest patients are at risk of having significant lesions at the cephalic arch within 3\u2009months after the previous intervention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02728-4","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T04:40:34Z","timestamp":1647578434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cephalic arch restenosis rates in hemodialysis patients with brachiocephalic fistulae: a retrospective multicenter analysis of 3301 patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Rishi N.","family":"Razdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len A.","family":"Usvyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"2728_CR1","volume-title":"USRDS annual data report: epidemiology of kidney disease in the United States","author":"United States Renal Data System","year":"2020","unstructured":"United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2020."},{"issue":"5","key":"2728_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2215\/CJN.01080307","volume":"2","author":"CE Lok","year":"2007","unstructured":"Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2(5):1043\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"2728_CR3","doi-asserted-by":"publisher","first-page":"S299","DOI":"10.21037\/cdt.2017.09.08","volume":"7","author":"KB Quencer","year":"2017","unstructured":"Quencer KB, Oklu R. Hemodialysis access thrombosis. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S299\u2013308.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"4","key":"2728_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2214\/AJR.15.14650","volume":"205","author":"KB Quencer","year":"2015","unstructured":"Quencer KB, Arici M. Arteriovenous fistulas and their characteristic sites of stenosis. Am J Roentgenol. 2015;205(4):726\u201334.","journal-title":"Am J Roentgenol"},{"issue":"2","key":"2728_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1148\/radiol.2322030714","volume":"232","author":"DK Rajan","year":"2004","unstructured":"Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty--are there clinical predictors of patency? Radiology. 2004;232(2):508\u201315.","journal-title":"Radiology"},{"issue":"12","key":"2728_CR6","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/ndt\/15.12.2029","volume":"15","author":"L Turmel-Rodrigues","year":"2000","unstructured":"Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant. 2000;15(12):2029\u201336.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2728_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/01.RVI.0000071090.76348.BC","volume":"14","author":"DK Rajan","year":"2003","unstructured":"Rajan DK, Clark TW, Patel NK, Stavropoulos SW, Simons ME. Prevalence and treatment of cephalic arch stenosis in dysfunctional autogenous hemodialysis fistulas. J Vasc Interv Radiol. 2003;14(5):567\u201373.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2728_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1525-139X.2007.00387.x","volume":"21","author":"K Kian","year":"2008","unstructured":"Kian K, Asif A. Cephalic arch stenosis. Semin Dial. 2008;21(1):78\u201382.","journal-title":"Semin Dial"},{"issue":"4 Suppl 2","key":"2728_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","volume":"75","author":"CE Lok","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1\u2013S164.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2728_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1542-4758.2006.00087.x","volume":"10","author":"RP Campos","year":"2006","unstructured":"Campos RP, Do Nascimento MM, Chula DC, Do Nascimento DE, Riella MC. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int. 2006;10(2):152\u201361.","journal-title":"Hemodial Int"},{"issue":"1","key":"2728_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1542-4758.2008.00246.x","volume":"12","author":"M Hammes","year":"2008","unstructured":"Hammes M, Funaki B, Coe FL. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodial Int. 2008;12(1):85\u20139.","journal-title":"Hemodial Int"},{"issue":"6","key":"2728_CR12","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jvs.2008.07.071","volume":"48","author":"D Shemesh","year":"2008","unstructured":"Shemesh D, Goldin I, Zaghal I, Berlowitz D, Raveh D, Olsha O. Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: a prospective randomized clinical trial. J Vasc Surg. 2008;48(6):1524\u201331 1531 e1521\u20131522.","journal-title":"J Vasc Surg"},{"issue":"9","key":"2728_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jvir.2015.05.001","volume":"26","author":"DK Rajan","year":"2015","unstructured":"Rajan DK, Falk A. A randomized prospective study comparing outcomes of angioplasty versus VIABAHN stent-graft placement for cephalic arch stenosis in dysfunctional hemodialysis accesses. J Vasc Interv Radiol. 2015;26(9):1355\u201361.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"2728_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1129729818814466","volume":"20","author":"RT D'Cruz","year":"2019","unstructured":"D'Cruz RT, Leong SW, Syn N, Tiwari A, Sannasi VV, Singh Sidhu HR, et al. Endovascular treatment of cephalic arch stenosis in brachiocephalic arteriovenous fistulas: a systematic review and meta-analysis. J Vasc Access. 2019;20(4):345\u201355.","journal-title":"J Vasc Access"},{"issue":"2","key":"2728_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jvs.2017.08.018","volume":"67","author":"GA Miller","year":"2018","unstructured":"Miller GA, Preddie DC, Savransky Y, Spergel LM. Use of the Viabahn stent graft for the treatment of recurrent cephalic arch stenosis in hemodialysis accesses. J Vasc Surg. 2018;67(2):522\u20138.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2728_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.ATV.2.2.125","volume":"2","author":"DP Faxon","year":"1982","unstructured":"Faxon DP, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis. 1982;2(2):125\u201333.","journal-title":"Arteriosclerosis"},{"issue":"5","key":"2728_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2007.07.019","volume":"50","author":"P Roy-Chaudhury","year":"2007","unstructured":"Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50(5):782\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2728_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5301\/jva.5000203","volume":"15","author":"G Sivananthan","year":"2014","unstructured":"Sivananthan G, Menashe L, Halin NJ. Cephalic arch stenosis in dialysis patients: review of clinical relevance, anatomy, current theories on etiology and management. J Vasc Access. 2014;15(3):157\u201362.","journal-title":"J Vasc Access"},{"issue":"1","key":"2728_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0036-1571806","volume":"33","author":"G McLennan","year":"2016","unstructured":"McLennan G. Stent and stent-graft use in Arteriovenous dialysis access. Semin Interv Radiol. 2016;33(1):10\u20134.","journal-title":"Semin Interv Radiol"},{"key":"2728_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jss.2018.01.030","volume":"226","author":"H Hu","year":"2018","unstructured":"Hu H, Wu Z, Zhao J, Wang J, Huang B, Yang Y, et al. Stent graft placement versus angioplasty for hemodialysis access failure: a meta-analysis. J Surg Res. 2018;226:82\u20138.","journal-title":"J Surg Res"},{"issue":"6","key":"2728_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa0902045","volume":"362","author":"ZJ Haskal","year":"2010","unstructured":"Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362(6):494\u2013503.","journal-title":"N Engl J Med"},{"issue":"5","key":"2728_CR22","first-page":"4144","volume":"18","author":"J Kavan","year":"2019","unstructured":"Kavan J, Kudlicka J, Malik J, Chytilova E, Lambert L, Slavikova M, et al. Treatment of failing arterio-venous dialysis graft by angioplasty, stent, and stent graft: two-years analysis of patency rates and cost-effectiveness. Exp Ther Med. 2019;18(5):4144\u201350.","journal-title":"Exp Ther Med"},{"issue":"6","key":"2728_CR23","doi-asserted-by":"publisher","first-page":"e044356","DOI":"10.1136\/bmjopen-2020-044356","volume":"11","author":"B Ng","year":"2021","unstructured":"Ng B, Fugger M, Onakpoya IJ, Macdonald A, Heneghan C. Covered stents versus balloon angioplasty for failure of arteriovenous access: a systematic review and meta-analysis. BMJ Open. 2021;11(6):e044356.","journal-title":"BMJ Open"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02728-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02728-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02728-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T04:40:56Z","timestamp":1647578456000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02728-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2728"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02728-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"15 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This analysis was conducted under a protocol that was reviewed and approved by New England Independent Review Board (IRB) (Needham Heights, MA, United States; NEIRB#WO-1-574-1). The IRB approved the protocol under an Exempt Category since the analysis used deidentified patient data that did not include Protected Health Information and written\/verbal informed consent was not required nor applicable per the Code of Federal Regulations (45CFR46) in the United States. This study adhered with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Fresenius Medical Care, or its subsidiary company Azura Vascular Care. L.A.U. has share options\/ownership in Fresenius Medical Care. L.A.U., J.W.L. are an inventor on patent(s) in the field of dialysis. J.W.L. is a guest editor on the Editorial Board of Frontiers in Physiology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}